These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22924366)

  • 21. Osteopathology induced by bisphosphonates and dental implants: clinical observations.
    Jacobsen C; Metzler P; Rössle M; Obwegeser J; Zemann W; Grätz KW
    Clin Oral Investig; 2013 Jan; 17(1):167-75. PubMed ID: 22415216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
    Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
    Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
    Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.
    Fernández Ayora A; Herion F; Rompen E; Reginster JY; Magremanne M; Lambert F
    J Clin Periodontol; 2015 Feb; 42(2):190-5. PubMed ID: 25327450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dental implant placement with bone augmentation in a patient who received intravenous bisphosphonate treatment for osteoporosis.
    Mattheos N; Caldwell P; Petcu EB; Ivanovski S; Reher P
    J Can Dent Assoc; 2013; 79():d2. PubMed ID: 23763726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.
    Holzinger D; Seemann R; Matoni N; Ewers R; Millesi W; Wutzl A
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1937.e1-8. PubMed ID: 25234534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
    Kwon TG; Lee CO; Park JW; Choi SY; Rijal G; Shin HI
    Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?
    Kwon YD; Ohe JY; Kim DY; Chung DJ; Park YD
    Clin Oral Implants Res; 2011 Jan; 22(1):100-5. PubMed ID: 20946206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
    Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
    Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
    Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw.
    Heufelder MJ; Hendricks J; Remmerbach T; Frerich B; Hemprich A; Wilde F
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):e429-35. PubMed ID: 23182374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
    Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
    Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report.
    Alsalleeh F; Keippel J; Adams L; Bavitz B
    J Endod; 2014 Sep; 40(9):1505-7. PubMed ID: 25146044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.